Mark J. Gergen

2014 - Mirati Therapeutics

In 2014, Mark J. Gergen earned a total compensation of $1.3M as Executive Vice President and Chief Operations Officer at Mirati Therapeutics, a 13% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$92,360
Option Awards$762,828
Salary$399,180
Other$2,975
Total$1,257,343

Gergen received $762.8K in option awards, accounting for 61% of the total pay in 2014.

Gergen also received $92.4K in non-equity incentive plan, $399.2K in salary and $3K in other compensation.

Rankings

In 2014, Mark J. Gergen's compensation ranked 6,551st out of 13,032 executives tracked by ExecPay. In other words, Gergen earned more than 49.7% of executives.

ClassificationRankingPercentile
All
6,551
out of 13,032
50th
Division
Manufacturing
2,390
out of 4,966
52nd
Major group
Chemicals And Allied Products
805
out of 1,686
52nd
Industry group
Drugs
629
out of 1,365
54th
Industry
Pharmaceutical Preparations
480
out of 1,043
54th
Source: SEC filing on April 19, 2016.

Gergen's colleagues

We found two more compensation records of executives who worked with Mark J. Gergen at Mirati Therapeutics in 2014.

2014

Charles Baum

Mirati Therapeutics

Chief Executive Officer

2014

James Christensen

Mirati Therapeutics

Chief Scientific Officer

News

In-depth

You may also like